Towards artificial intelligence-driven pathology assessment for hematological malignancies.

TitleTowards artificial intelligence-driven pathology assessment for hematological malignancies.
Publication TypeJournal Article
Year of Publication2021
AuthorsElemento O
JournalBlood Cancer Discov
Volume2
Issue3
Pagination195-197
Date Published2021 May
ISSN2643-3249
Abstract

In this issue of Blood Cancer Discovery, Brück applied unsupervised and supervised machine learning to bone marrow histopathology images from Myelodysplastic Syndrome (MDS) patients. Their study provides new insights into the pathobiology of MDS and paves the way for increased use of artificial intelligence for the assessment and diagnosis of hematological malignancies.

DOI10.1158/2643-3230.bcd-21-0048
Alternate JournalBlood Cancer Discov
PubMed ID34027414
PubMed Central IDPMC8133372
Grant ListR01 CA194547 / CA / NCI NIH HHS / United States
UG3 CA244697 / CA / NCI NIH HHS / United States
UL1 TR002384 / TR / NCATS NIH HHS / United States